/ /

  • linkedin
  • Increase Font
  • Sharebar

    Laser advances take retina specialty to new levels of treatment, care

    Artificial retina, genetic engineering, stem cell therapies also generate interest


    Human clinical trials are under way for stem cell-mediated treatment of Stargardt’s macular dystrophy, and similar trials for AMD are just around the corner, he said. 


    Pravin U. Dugel, MD

    E: [email protected]

    Dr. Dugel is a consultant to Acucela, Alcon Laboratories, Alimera, Allergan, Genentech, and Novartis, and is a consultant to and a minor shareholder in Aerpio and Ophthotech.


    Michael S. Ip, MD

    E: [email protected]

    Dr. Ip has no financial interest in any aspect of this report.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results